Blockchain in Pharmaceutical Supply Chain Management Market Analysis Based on Development Strategy, Industry Statistics, and Future Prospects

 The Global Blockchain in Pharmaceutical Supply Chain Management Market size is expected to register a CAGR of 22.5% during the forecast period of 2019 to 2024.

A blockchain solution can make a substantive difference to the pharmaceutical supply chain. At every stage of the supply chain process, barcodes would be scanned and recorded onto a blockchain ledger system which, in sequence, records and creates an audit trail of the drug journey. Sensors can also be combined into the supply chain, with temperature or humidity being noted onto the ledger system. This is most important for drugs requiring fridge storage, such as insulin or expensive, specially manufactured medicines.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8009 

Furthermore, through the use of blockchain, the supply chain process of the drugs can become more secure and streamlined. Every delivery can be tracked, with the delivery driver traced through biometric measures. Every checkpoint concerning the drugs supply is recorded and traced via biometric measures, 2d barcode scans, or sensor technology. As the drug is tracked from its manufacturing unit to the patient, the whole of the drug supply chain becomes seamless, precise, audited, and safe.

Segmentation

The global blockchain in pharmaceutical supply chain management is segmented on the basis of application, end user, and region.

On the basis of application, the global blockchain in pharmaceutical supply chain management market is segmented into product traceability, risk and compliance management, payment & settlement, others. The market by end user is segmented into manufacturers, distributors, healthcare providers

On the bases of region, the global blockchain in pharmaceutical supply chain management market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to hold the largest market share and the Middle East & Africa with a low market share during the forecasted period.

Key Players

Some of the key players in the global blockchain in pharmaceutical supply chain management market are IBM, Microsoft, SAP SE, Oracle, Tibco Software, Auxesis Group, Omnichain, Vechain Foundation, Chainvine, Applied Blockchain, AWS, Huawei, Guardtime, BTL Group, Bitfury, Digital Treasury Corporation, Blockverify, Nodalblock, Peer Ledger and others.

Regional Analysis

The healthcare sector and its supporting IT infrastructure are going through dramatic changes, all of which impact the claims management process and lead to improving the technology. Many healthcare organizations use robotic process automation, intelligent EDI integration, insurance discovery, and patient solutions all within their workflow platform to dramatically enhance the overall process. The adoption of various software has increased profit.

Infrastructure and technology are continuously evolving in developing regions such as Asia-Pacific. A number of different multinational and local companies are involved in developing their markets in this region owing to the developing economy and increasing government support. An increasing number of healthcare companies have provided a good opportunity for the development of the blockchain in pharmaceutical supply chain management market.

Furthermore, in the United States, the Drugs Quality and Safety Act (DQSA) was promoted by Congress on November 27, 2013. This outlines the steps to be taken to develop an interoperable electronic supply chain management system. This will strengthen the FDA's capability to protect consumers from exposure to drugs that could be fake or from the black market.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/blockchain-pharmaceutical-supply-chain-management-market-8009 

 

Nanobiosensors in Healthcare Market to Reap Excessive Revenues by 2020-2027

 Global Nanobiosensors in Healthcare Market is expected to register a CAGR of 9.84% from 2019 to 2024.

Nanotechnology in the biosensor is known as nanobiosensor; biosensors are analytical devices used for detection of chemical and biological substances in the human body. Nanobiosensors are the sensors that are made up of nanomaterials and have dimensions between 1 to 100 nanometers. Nanobiosensors are becoming popular in developed countries. The rising prevalence of diabetes in emerging economies, demand for advanced monitoring systems, and raising awareness about advance nanobiosensors are expected to drive the growth of the market. According to the International Diabetes Federation (IDF), it is estimated that the number of diabetic patients in the Middle East and North Africa (MENA) region will grow by 96% from the year 2013 to 2035, i.e., from 34.6 million to 67.9 million. Moreover, rising R&D spending and collaborative strategies adopted by the top players, such as new product launches and collaborations for product development are contributing to the growth of the market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7993 

The rising cost of nanobiosensors and unfavorable reimbursement policies may hamper the growth of the market during the assessment period.

Segmentation

The global nanobiosensors in healthcare market has been segmented on the basis of type, application, end user, and region.

On the basis of type, the market has been classified as optical nanobiosensor, electrochemical nanobiosensor, acoustic nanobiosensor, and others. The electrochemical nanobiosensor segment is expected to hold the largest market share of the nanobiosensors in healthcare market owing to its high sensitivity and real-time detection features. Based on the nanobiosensors in healthcare market application, the market has been segmented into diabetes, immunoassay, cancer, pathogenic bacteria, and others. The market, by end user, has been divided into as hospitals and clinics, diagnostic centers, point of care, and others. However, based on end user point of care testing segment holds the largest market share due to low complex infrastructure and training.

Key Players

Some of the prominent key players in the global nanobiosensors in healthcare market are Abbott Point of Care, Inc., F. Hoffman-LA Roche Ltd., Medtronic Inc., Nano-Proprietary, Inc., Lifescan, Inc., Illuminex Corporation, Lifesensors, Inc., ACON Laboratories, Inc., Pharmaco-Kinesis Corporation, Bayer Healthcare AG, Bio-Rad Laboratories, Inc., Biosensors International Pte. Ltd., Sysmex Corporation.

Regional Analysis

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The nanobiosensors in healthcare market in the Americas has further been segmented into North America and South America, with the North America market further classified into the US and Canada.

The European nanobiosensors in healthcare market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 

The nanobiosensors in healthcare market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The nanobiosensors in healthcare market in the Middle East & Africa has been segmented into the Middle East and Africa.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/nanobiosensors-in-healthcare-market-7993 

 

Dental Lasers Market Growth, Demands, CAGR, Sales Volume, Opportunities, Types, Applications and Forecast up to 2027

 The global Dental Lasers Market is estimated reach USD 2.3 billion by 2023 with a CAGR of 5.2% during the forecast period (2017-2023).

The term “LASER” stands for ‘Light Amplification by the Stimulated Emission of Radiation’. Lasers emit a thin and concentrated beam of light, producing a thermal output. This thermal output has been used in the dentistry for endodontic treatment, oral surgery, implantology, peri-implantitis, periodontics, and others.

From the past few years, the dental laser market has expanded with a steady CAGR. Factors such as, increasing prevalence of dental diseases, rising dental healthcare expenditure, growing R&D by the major market players, and increasing dental tourism are estimated to drive the market during the forecast period. Dental caries is a common chronic tooth tissue disease and effects ~90% of the world population (once in the lifetime). In the presence of such high prevalence of dental caries, demand of related therapeutics has increased. It is reportable that dental caries can be removed effectively by the application of dental lasers. Fast procedure and minimal invasion are some of the advantages associated with caries removal by dental lasers.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7375 

However, factors such as high cost of dental laser, changing reimbursement policies, lack of skilled work-force and awareness in the developing economies restraints the market growth.  A sophisticated laser system is estimated to cost about USD 300, 000 to USD 500,000 or more.

Segmentation

The global dental lasers market is segmented based on product, application, and end users.

The dental lasers market, by product is segmented into soft tissue dental lasers and all tissue dental lasers. The soft tissue dental lasers is sub-segmented into diode lasers systems, CO2 laser systems, and Nd:YAG laser systems. The all tissue dental lasers segment is divided into Er:YAG laser systems, and Er,Cr:YSGG laser systems. By application, the market is segmented into endodontic treatment, oral surgery, implantology, peri-implantitis, periodontics, and others. The dental lasers market, by end user is segmented into hospitals & clinics, ambulatory surgical units, academic & research organizations.

Regional Analysis

North America dominated the global market for dental lasers in 2017 owing to increasing prevalence of dental diseases, and high healthcare expenditure are estimated to drive the regional market. Following the Americas, Europe leads the market. Factors such as high dental healthcare expenditure, government support for the dental sector and increasing penetration of the market players within the region is estimated to provide favorable backgrounds of market growth within the region. Asia-Pacific is anticipated to be the rapidly growing region for the dental lasers market, owing to growth owing growing geriatric population, increasing awareness and rising preference for minimally invasive surgeries. Moreover, rapidly developing dental industry makes the region lucrative for market development and expansion. The Middle East and Africa stands the least dental lasers market share. This can be attributed due to low per capita income, less expenditure on the healthcare, and lack of advanced healthcare facilities within the region. 

Key Players

Some of the key players in the global dental lasers market are Amd Lasers, Biolase, Inc., Cao Group, Inc., Convergent Dental, Inc., Danaher Corporation- Kavo Dental GmbH, Fotona D.D., Ivoclar Vivadent AG, Millennium Dental Technologies, Inc., Sirona Dental Systems, Inc., Syneron Dental Lasers-Syneron Medical Ltd., The Yoshida Dental MFG. Co., Ltd., and Zolar Technology & MFG. Co. Inc.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/dental-lasers-market-7375 

 

Veterinary Laboratory Testing Market – Insights on Upcoming Trends 2027

 Global veterinary laboratory testing market is expected to grow significantly over the forecast period. It is anticipated that the market held a valuation of USD 2200 million in 2017 and is projected to grow at a CAGR of 10.1% over the forecast period.

The veterinary laboratory tests are usually performed to determine the cause of animal’s disorder.

Rising incidence of zoonotic diseases is one of the key factors driving the veterinary laboratory testing market. According to the Maine Center for Disease Control & Prevention, around 75% of emerging infectious diseases affecting humans are diseases of animal origin. The most commonly occurring zoonotic diseases are Rabies, Ebola Virus Disease, Q fever, and others. Various other factors such as rising awareness about animal diseases, technological advancements in veterinary testing, increasing expenditure on pet insurance and favourable funding policies are also expected to propel the growth of the market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7326 

However, high cost of veterinary testing and complications associated with the tests can hinder the market growth over the forecast period.

Key Players

Some of the prominent veterinary laboratory testing market companies are Abaxis, Inc., BIOCHECK Inc., Biomérieux SA, Henry Schein, Inc., Heska Corporation, Idexx Laboratories, Idvet, Neogen Corporation, Pfizer, Qiagen N.V., Randox Laboratories, Ltd., Thermo Fisher Scientific, VCA Inc., Virbac, Zoetis, Inc. and others.

Regional Analysis

Geographically, the Americas is anticipated to dominate the global veterinary laboratory testing market owing to the increasing cases of animal disease and technological advancements in veterinary diagnostics. For instance, in 2016, IDEXX Laboratories, Inc. launched the Rapid Visual Pregnancy Test for cattle. With the new test, veterinarians can more quickly identify open cows using whole blood samples collected before the farm visit. Europe is expected to hold the second largest position in the global veterinary laboratory testing market. The market growth in this region is attributed to the rising expenditure on pet insurance. The Veterinary Laboratory Testing Market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to the awareness regarding use of sterile consumables for lab testing and rising healthcare spending. The Middle East & Africa contributes least in the global market for veterinary laboratory testing.

Segmentation

The global veterinary laboratory testing market has been segmented into animal type, technology, product, and end user.

The market, on the basis of animal type, has been segmented into companion animal and livestock animal. The companion animal segment is further classified as dogs, cats, horses and others. The livestock animal segment is further classified as cattle, pigs, poultry and others.

The market, by technology, has been segmented into clinical biochemistry, immunodiagnostics, hematology, molecular diagnostics, urinalysis, and others.

The clinical biochemistry segment is further classified as clinical chemistry analysis, glucose monitoring, and blood gas & electrolyte analysis. The clinical chemistry analysis segment includes clinical chemistry reagent clips and cartridges and clinical chemistry analyzers. The glucose monitoring segment includes blood glucose strips, glucose monitors and urine glucose strips. The blood gas & electrolyte analysis segment includes blood gas and electrolyte reagent clips and cartridges and blood gas & electrolyte analyzers.

The immunodiagnostics segment is further classified as ELISA tests, lateral flow assays, allergen-specific immunodiagnostic tests, immunoassay analyzers, and others. The lateral flow assays segment includes lateral flow rapid tests, and lateral flow strip readers.

The hematology segment is further classified as hematology cartridges, and hematology analyzers.

The molecular diagnostics segment is further classified as polymerase chain reaction (PCR) tests, microarrays, and others.

The urinalysis segment is further classified as urinalysis clips & cartridges/panels, urine analyzers, and urine test strips.

The market, by product, has been segmented into consumables and instruments.

The market, by end user, has been segmented into veterinary hospitals & clinics, in-house testing, research institutes, diagnostic laboratories, and others. The veterinary hospitals & clinics segment held the largest segment of the market in 2017. This can be attributed to the increasing incidence of zoonotic diseases. On the other hand, the academic institutes segment is estimated to be the fastest growing segment.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/veterinary-laboratory-testing-market-7326 

 

Sleep Testing Services Market Current Trends, SWOT Analysis, Strategies, Industry Challenges, Business Overview and Forecast Research Study 2027

 Market Scenario

Global sleep testing services market analysis expected the market to grow significantly over the forecast period. It is anticipated that the market held a valuation of USD 5.9 billion in 2017 and is projected to grow at a CAGR of 13.2% over the forecast period. Sleep testing services are a set of medical tests that are used to recognize and diagnose sleeping disorders. They record breathing patterns, oxygen levels in blood, leg & eye movements, brainwaves and heart rate.

The factors such as increasing prevalence of sleep disorders, private insurance service providers and heavy adoption of the services by people are expected to propel the growth of the market. However, the high cost associated with sleep testing services can hamper the market growth over the forecast period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7275 

Regional Analysis

Geographically, the Americas is expected to dominate the global market owing to the high prevalence of various sleep disorders, rising awareness about the sleep testing services. According to an article published by the National Institute of Neurological Disorders and Stroke in July 2018, 135,000 to 200,000 people in the US are affected by narcolepsy, which is a disorder that affects the sleep-wake cycle of a person. Europe is expected to hold the second largest position in the global market owing to the increasing awareness about sleep testing services. Asia-Pacific is expected to be the fastest growing market owing to the rising prevalence of sleep disorders like insomnia, restless leg syndrome, etc. Moreover, the Middle East and Africa region is expected to account for the least market share in the global market.

Segmentation

The global sleep testing services market has been segmented into diagnostic services, treatment monitoring services and end user.

The market, on the basis of diagnostic services, has been segmented into home sleep testing and in-lab sleep testing. In-lab sleep testing is further segmented into electroencephalogram, full polysomnography, CPAP/BiPAP Titration, multiple sleep latency test (MSLT) and maintenance of wakefulness test (MWT).

The global market, on the basis of treatment monitoring services, has been segmented into obstructive sleep apnea, insomnia, restless legs syndrome, circadian rhythm disorders, narcolepsy and rapid eye movement (REM) sleep disorder.

The global sleep testing services market, by end user, has been segmented into hospitals, sleep centers, home care settings and others. The hospitals segments is expected to hold the largest market share owing to high preference of people visiting the hospitals for treating their disorders. Whereas the sleep centers are expected to grow at the fastest market share owing to increasing awareness among patients regarding the sleep centers.

Key Players

Some of the prominent players in the global sleep testing services market are St. Luke's, Medical Service Company, Midwest Sleep Diagnostics, Inc., Sleep Services Australia, Total Sleep Holdings, Inc., GenesisCare, Carolinas Sleep Services, SleepMed, SOVA Sleep Services, SleepWorks, LLC, HomeSleep, LLC and Others.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/sleep-testing-services-market-7275 

 

Medication Management Market – Revolutionary Trends 2027

 The Global medication management market is expected to register a CAGR of 13.4% during the forecast period of 2018 to 2023.

Medication management is a strategy which ensures that the patient understands the purpose of the medications and takes it in the correct manner at the correct time. It also focuses on improving the use of medications for the patient's condition. Interventions may include medication reconciliation, medication therapy management, patient/family education on medications and medication set-up simulations for the patient.

Rising geriatric population is one of the key factors driving the medication management market.  Older adults tend to have significant comorbidities which in result increase the medication use and escalate the risk of poor outcomes. According to a 2018 study published in the Clinical Epidemiology, in high income countries, polypharmacy affects between 40% and 50% of older adults. Polypharmacy increases the risk of adverse drug-related events in older adults because a higher number of drugs are associated with a higher risk of harmful drug–drug interactions.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7187 

Various other factors such as rising healthcare IT funds, and need for reducing healthcare costs.

However, high software implementation and service maintenance costs can hamper the market growth over the forecast period.

Key Players

Some of the global medication management market companies are Allscripts Healthcare Solutions, Inc., Carefusion Corporation (BD), Cerner Corporation, Epic Systems Corporation, General Electric Company, Mckesson Corporation, Medical Information Technology, Inc., Omnicell, Inc., Optum Inc., QuadraMed Affinity Corporation, Siemens Ltd and others.

Segmentation

The Global medication management market is segmented based on systems, services, mode of delivery, end user and region.

The global market for medication management, by systems is segmented into computerized physician order entry systems, clinical decision support systems, administration software, inventory management systems, automated dispensing systems and assurance systems. The administration software is further classified as electronic medication administration records (eMAR) software and bar code medication administration (BCMA) software. The automated dispensing systems segment is further classified as centralized automated dispensing systems and decentralized automated dispensing systems (ADS). The centralized automated dispensing system includes robots/robotic automated dispensing systems and carousels. The decentralized automated dispensing system (ADS) includes pharmacy-based decentralized automated dispensing systems, ward-based decentralized automated dispensing systems and automated unit-dose decentralized automated dispensing systems.

The market by services segment is divided into point-of-care verification services and adverse drug effects (ADE) surveillance services.

The market by mode of delivery segment is divided into web-based solutions, on-premise solutions and cloud-based solutions.

Based on end-user, the market is segmented into hospitals, pharmacies and others.

Regional Analysis

The Americas dominated the global market for medication management. This can be attributed to the increasing geriatric population and presence of major market players within the region.

Europe stood second in 2017 owing to the presence of developed economies like UK, Germany, France, and others within the region provides a driving force for the market to grow.

Asia Pacific was projected to be the fastest growing region in 2017. Factors such as growing healthcare IT sector, increasing penetration of the market players within the region, and increasing government’s support for foreign investments drives the regional markets of the Asia Pacific region.

On the other hand, the Middle East and Africa held least share in the global medication management market due to the presence of poor economies and low per capita income, especially within the African region. The Middle Eastern region is estimated to be a major market for the Middle East and African region.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/medication-management-market-7187 

 

Surgical Microscopes Market: Recent Industry Trends and Projected Industry Growth, 2020– 2027

 The global Surgical Microscopes Market Forecast is expected to grow significantly over the forecast period. The market held a market value of USD 574.34 million in 2017 and is projected to grow at a CAGR of 11.63% over the forecast period.

Surgical microscopes are the optical microscopes specially designed for the use in surgical settings. These surgical microscopes have a high magnification resolution which is highly beneficial during the microsurgeries. Also, surgical microscopes can be customized which is helpful for the component sterilization, and disinfection to ensure the complete cross-infection control. Generally, even the basic surgical microscopes can cost up to several thousand dollars. The advanced versions of such microscopes have high price points. There are several factors that fuel the growth of the global surgical microscopes market. These include, increasing number of surgical procedures, high demand for the minimally invasive surgeries, and continuous development in the medical sector to come up with better surgical approaches. Moreover, development of customized microscopy solutions, and increasing use of fluorescence image-guided surgery (FIGS) is expected to boost the growth of the market during the forecast period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7065 

On the other hand, there are several factors such as high cost of the microscopic devices, stringent regulatory norms, and lack of required medical infrastructure in the developing and underdeveloped regions which are likely to thwart the growth of the surgical microscopes market to an extent.

Regional Analysis:

Geographically, the Americas is anticipated to dominate the global surgical microscopes market owing to the, rising number of the neurosurgeries, spinal surgeries, and ophthalmic surgeries, increasing awareness about dental hygiene leading to increase in dental procedures and surgeries. The development of the better surgical approaches and advanced treatment procedures have positively affected the growth of the American market. Moreover, high awareness among American population, state of the art medical infrastructure, high disposable income, are some of the many factors that drive the growth of the surgical microscopes market in this region.

Europe is expected to hold the second largest market share in the global surgical microscopes market. The market growth in this region is majorly attributed to the presence of large number of market players in the region and increasing government support for the device manufacturers. Geographical expansion of companies has led to the wider reach of the medical products and services which has brought a huge change in terms of the acceptance and implementation of the new products as well as procedures. Similarly, Asia-Pacific region has observed a rapid growth in the surgical microscopes market owing to increased rate in neurosurgeries in the Asian region. Moreover, the development in the medical sector in developing countries like India and China. Moreover, increase in government funding for healthcare, rising R&D expenditure, and growing number of medical device companies in the region has led to its fastest growth during the forecast period. The Middle East & Africa region is anticipated to show minor growth opportunities in the surgical microscopes market during the forecast period.

Segmentation:

The Global Surgical Microscopes Market. has been segmented into type, application and end user.

Based on types, the market has been segmented into, On casters microscopes, wall mounted microscopes, table top microscopes, and ceiling mounted microscopes. The on casters microscopes segment is expected to account for the largest share in the global surgical microscopes market in 2017. This large share is majorly attributed to its convenience in the use as compared to other products.

Based on application, the market has been segmented into neurosurgery & spine surgery, ophthalmology, ENT surgery, dentistry, oncology, plastic & reconstructive surgery, urology, gynecology, and other. The neurosurgery & spine surgery segment is expected to account for the largest share in the global surgical microscopes market in 2017 followed by ophthalmology segment.

Based on end users, the market has been segmented into hospitals, physician’s clinic, academic and research institutes, and other outpatient settings. The hospitals segment is expected to account for the largest share in the global surgical microscopes market in 2017. At the same time, the high awareness about the aesthetics, dental hygiene and increasing rate of ophthalmic surgical cases in the developed and developing countries has led physician’s clinic segment to grow at the fastest rate during the forecast period.

Based on the regions, the market for surgical microscopes is segmented in to, the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The surgical microscopes market in the Americas region has further been segmented into North America and South America, where-in the North American market is further divided into the US and Canada.

European surgical microscopes market has been segmented into Western Europe and Eastern Europe where-in Western Europe region is further divided into Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 

The surgical microscopes market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The surgical microscopes market in the Middle East & Africa has been segmented into regions such as the Middle East & Africa.

Key Players:

Some of the prominent players in the global surgical microscopes market are Accu-Scope Inc., Alltion (Wuzhou) Co., Ltd., Arri Medical (Arri Group), Carl Zeiss AG, Danaher Corporation, Haag-Streit Surgical GmbH, Leica Microsystems GmbH, Novartis AG, Olympus Corporation, Seiler Precision Microscopes, Takagi Seiko Co. Ltd., and Topcon Medical Systems, Inc.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/surgical-microscopes-market-7065